from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3614c/espD

LFCtreatmentdescriptionclass of inhibitor

-0.578

Amikacinug/mL Amikacintranslation

-0.458

Cap5-10ug/mL Capreomycintranslation

-0.468

Rox10-50 ug/mL Roxithromycintranslation

0.474

SM2-5 ug/mL Streptomycintranslation

-0.795

Tet5-10 ug/mL Tetracyclinetranslation

-1.327

Rif0.2-5ug/mL Rifampicintranscription

-0.405

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.527

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.966

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.081

CPZ10-50 ug/mL Chlorpromazinerespiration

0.901

Clofazimine10-13 ug/mL Clofaziminerespiration

0.262

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.311

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.231

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.320

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.197

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.272

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.205

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.166

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.812

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.006

KCN5-20 ug/mL Potassium cyaniderespiration

1.909

NaN30.2-2 mM Sodium aziderespiration

0.674

Nigericin50 uM Nigericinrespiration

0.445

TRC10-150 ug/mL Triclosanrespiration

0.696

TRZ10-25 ug/mL Thioridazinerespiration

-0.888

Valinomycin0.5-10 uM Valinomycinrespiration

1.145

ZnSO42 mM ZnSO4respiration

-1.416

menadione6-10 ug/mL Menadionerespiration

0.180

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.036

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.040

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.033

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.953

NRP_1Non-replicating persistence stage 1dosRassociated

0.056

Amp0.2mg/mL AmpicillincellWall

-0.248

Cephalexin20-100 ug/mL CephalexincellWall

-1.108

Cerulenin0.32-5 ug/mL CerulenincellWall

0.159

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.634

EMB10-20 ug/mL EthambutolcellWall

-0.925

Eta12-40 ug/mL EthionamidecellWall

-1.330

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.992

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.742

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.156

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.262

BZA0.12 mg/mL BenzamidearomaticAmides

-0.316

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.352

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.734

H2O24 mM hydrogen peroxideDNAdamaging

0.040

Levo10 ug/mL LevofloxacinDNAdamaging

0.041

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.511

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.643

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.034

UVUV-irradiationDNAdamaging

0.063

ARP41-4 ug/mL Antitubercular compound ARP4?

0.364

Antimycin12.5-50 ug/mL Antimycin A?

0.306

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.591

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.270

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.983

PA8240.2-2 ug/mL PA-824?

-0.653

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.617

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.619

Verapamil50 uM Verapamil?

0.437

mercaptoethanol2 mM 2-Mercaptoethanol?

0.011

methoxatin10-20 ug/mL Methoxatin?